Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2016

View Archived Issues

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Mitsubishi Tanabe begins phase II trial of MT-3995 in NASH

Obeticholic acid granted positive CHMP opinion as treatment of primary biliary cholangitis

PhoreMost and University of Cambridge collaborate to identify novel targets

Japan Tobacco and JW Pharmaceutical enter license agreement for JTZ-951 in Republic of Korea

Clinical trial update for the INEXAS phase IIa study evaluating AZD-9412 in patients with asthma

Sunesis Pharmaceuticals submits response to EMA regarding vosaroxin MAA

Early first-in-human results indicate PTC-596 can achieve active plasma levels in cancer patients

EMA committee recommends approval of Rekovelle

Inhibition of APOBEC3B activity improves clinical benefit of tamoxifen in breast cancer

Allegro Ophthalmics' DEL MAR study meets primary and secondary endpoints

Clementia Pharmaceuticals reports positive results from phase II study of palovarotene

NEDD4L plays a critical role in the regulation of cortex development

Hua reports promising phase II results of glucokinase activator HMS-5552

TSHZ3 identified as a new gene linked to autism spectrum disorders

Myocardial PET imaging with CardioPET shows promise in phase II study

Bristol-Myers Squibb receives positive CHMP opinion for nivolumab

Leopold-Franzens Universitaet Innsbruck patents KOR agonists

Zhejiang Hisun Pharmaceutical discloses romidepsin analogues

Cancer Research Technology describes HSF1 inhibitors

Merck KGaA develops ATM kinase inhibitors

Cynata reports promising preclinical findings for MSC technology in mouse model of asthma

Toray Industries presents analgesic agents

Novel BICD2 mutations may cause SMALED2

AbbVie receives positive opinion for Venclyxto tablets in patients with difficult-to-treat CLL

FDA grants orphan drug designation to Genentech's atezolizumab in SCLC

DNAJB6 mutation is associated with myofibrillar myopathies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...